Brief: Xencor Says New Collaboration Agreement Effective June 1, 2024, To Replace Current Collaboration And License Agreement Between Co And Roche

Xencor

15/11/2023 21:59

Nov 15 (Reuters) - Xencor Inc  XNCR.O :
    * XENCOR INC - ON NOV 14 ENTERED AMENDED AND RESTATED
COLLABORATION AND LICENSE AGREEMENT WITH GENENTECH, INC
    * XENCOR INC -  NEW COLLABORATION AGREEMENT EFFECTIVE JUNE
1,
2024, TO REPLACE CURRENT COLLABORATION AND LICENSE AGREEMENT
BETWEEN CO AND ROCHE
    * XENCOR INC -  EXERCISED OPTION UNDER ORIGINAL AGREEMENT TO
CONVERT ITS CURRENT ARRANGEMENT INTO ROYALTY AND MILESTONE
PAYMENT FINANCIAL ARRANGEMENT
    * XENCOR INC -  TO BE ENTITLED TO RECEIVE UP TO $600 MILLION
IN
MILESTONES
    * XENCOR INC - PURSUANT TO NEW COLLABORATION AGREEMENT
GENENTECH
TO ASSUME SOLE RESPONSIBILITY OVER ALL CLINICAL, REGULATORY, AND
COMMERCIAL ACTIVITIES

Further company coverage:  XNCR.O 

 ((reuters.briefs@thomsonreuters.com;))